Literature DB >> 19430765

Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys.

Matthew L Banks1, Monica L Andersen, Kevin S Murnane, Rebecca C Meyer, Leonard L Howell.   

Abstract

RATIONALE: Diphenhydramine (DPH) is an over-the-counter medication used in the treatment of allergic symptoms. While DPH abuse is infrequent, recent preclinical evidence suggests that DPH and cocaine combinations may have enhanced reinforcing properties.
OBJECTIVE: The aims were to assess the reinforcing effectiveness of cocaine and DPH alone or in combination under a second-order schedule of reinforcement and to examine the neurochemical basis of this interaction using in vivo microdialysis in awake rhesus monkeys.
MATERIALS AND METHODS: Cocaine (0.03-0.3 mg/kg per injection), DPH (0.3-3.0 mg/kg per injection), or a combination was available under a second-order schedule of intravenous drug reinforcement (n = 3). In microdialysis studies, noncontingent cocaine (0.1-1.0 mg/kg, iv), DPH (1.7 and 3.0 mg/kg, iv), or a combination was administered and changes in extracellular dopamine levels in the caudate nucleus were examined (n = 3-5).
RESULTS: Cocaine and DPH dose-dependently maintained operant responding. Dose combinations of 1.0 or 1.7 mg/kg per injection DPH and 0.03 mg/kg per injection cocaine maintained greater rates of operant responding than 0.03 mg/kg per injection cocaine alone in the second component of the behavioral session. In microdialysis studies, cocaine dose-dependently increased extracellular dopamine levels, but no dose of DPH tested significantly increased dopamine levels above baseline. Moreover, combining DPH with cocaine did not enhance cocaine-induced dopamine increases.
CONCLUSIONS: The results support previous evidence of enhanced reinforcement with cocaine and DPH combinations and extend this finding to operant behavior maintained under a second-order schedule. However, the reinforcing effects of DPH alone or in combination with cocaine do not appear to be mediated via changes in dopamine overflow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430765      PMCID: PMC3233267          DOI: 10.1007/s00213-009-1555-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum.

Authors:  S N Haber; J L Fudge; N R McFarland
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol.

Authors:  J Bergman; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

3.  Some behavioral effects of histamine H1 antagonists in squirrel monkeys.

Authors:  J Bergman; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

4.  Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.

Authors:  K M Wilcox; K P Lindsey; J R Votaw; M M Goodman; L Martarello; F I Carroll; L L Howell
Journal:  Synapse       Date:  2002-01       Impact factor: 2.562

5.  Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Paul W Czoty; Brett C Ginsburg; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

6.  Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey.

Authors:  J W McKearney
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.

Authors:  Jae H Jun; Eric B Thorndike; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

8.  Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Pharmacol Biochem Behav       Date:  2008-10-07       Impact factor: 3.533

9.  Psychomotor stimulant effects of the stereoisomers of chlorpheniramine.

Authors:  J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Authors:  Kimberly P Lindsey; Kristin M Wilcox; John R Votaw; Mark M Goodman; Christophe Plisson; F Ivy Carroll; Kenner C Rice; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2004-02-24       Impact factor: 4.030

View more
  8 in total

1.  The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.

Authors:  K S Murnane; H L Kimmel; K C Rice; L L Howell
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

2.  The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent.

Authors:  Barbara Gracious; Naomi Abe; Jane Sundberg
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

3.  Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

Authors:  Erik B Oleson; Mark J Ferris; Rodrigo A España; Jill Harp; Sara R Jones
Journal:  Eur J Pharmacol       Date:  2012-03-15       Impact factor: 4.432

4.  Functional connectivity in frontal-striatal brain networks and cocaine self-administration in female rhesus monkeys.

Authors:  K S Murnane; K S Gopinath; E Maltbie; J B Daunais; Q K Telesford; L L Howell
Journal:  Psychopharmacology (Berl)       Date:  2014-08-21       Impact factor: 4.530

5.  Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.

Authors:  K S Murnane; W E Fantegrossi; J R Godfrey; M L Banks; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2010-05-13       Impact factor: 4.030

6.  Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.

Authors:  Kevin S Murnane; Monica L Andersen; Kenner C Rice; Leonard L Howell
Journal:  J Sleep Res       Date:  2013-10       Impact factor: 3.981

7.  Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys.

Authors:  Robert E Brutcher; Susan H Nader; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2015-12-07       Impact factor: 4.030

8.  Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates.

Authors:  Kevin S Murnane; Jake Winschel; Karl T Schmidt; LaShaya M Stewart; Samuel J Rose; Kejun Cheng; Kenner C Rice; Leonard L Howell
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.